243 related articles for article (PubMed ID: 37236764)
21. Adenosine A
Hanif A; Agba SO; Ledent C; Tilley SL; Morisseau C; Nayeem MA
Mol Cell Biochem; 2021 May; 476(5):1965-1978. PubMed ID: 33511551
[TBL] [Abstract][Full Text] [Related]
22. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
[TBL] [Abstract][Full Text] [Related]
23. Arachidonic acid cytochrome P450 epoxygenase pathway.
Spector AA
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
[TBL] [Abstract][Full Text] [Related]
24. Alteration of epoxyeicosatrienoic acids in the liver and kidney of cytochrome P450 4F2 transgenic mice.
Zhang B; Lai G; Liu X; Zhao Y
Mol Med Rep; 2016 Dec; 14(6):5739-5745. PubMed ID: 27878278
[TBL] [Abstract][Full Text] [Related]
25. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
26. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
27. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
Shahabi P; Siest G; Visvikis-siest S
Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
[TBL] [Abstract][Full Text] [Related]
28. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
29. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol.
Althurwi HN; Maayah ZH; Elshenawy OH; El-Kadi AO
Drug Metab Dispos; 2015 Aug; 43(8):1254-66. PubMed ID: 26033621
[TBL] [Abstract][Full Text] [Related]
30. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
31. Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice.
Hoopes SL; Gruzdev A; Edin ML; Graves JP; Bradbury JA; Flake GP; Lih FB; DeGraff LM; Zeldin DC
PLoS One; 2017; 12(4):e0175348. PubMed ID: 28384353
[TBL] [Abstract][Full Text] [Related]
32. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes.
Anita NZ; Kwan F; Ryoo SW; Major-Orfao C; Lin WZ; Noor S; Lanctôt KL; Herrmann N; Oh PI; Shah BR; Gilbert J; Assal A; Halperin IJ; Taha AY; Swardfager W
J Lipid Res; 2023 Jul; 64(7):100395. PubMed ID: 37245563
[TBL] [Abstract][Full Text] [Related]
34. Roles of the epoxygenase CYP2J2 in the endothelium.
Askari A; Thomson SJ; Edin ML; Zeldin DC; Bishop-Bailey D
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():56-63. PubMed ID: 23474289
[TBL] [Abstract][Full Text] [Related]
35. The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases.
Xu X; Li R; Chen G; Hoopes SL; Zeldin DC; Wang DW
Adv Nutr; 2016 Nov; 7(6):1122-1128. PubMed ID: 28140329
[TBL] [Abstract][Full Text] [Related]
36. Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy.
ElKhatib MAW; Isse FA; El-Kadi AOS
Drug Metab Rev; 2023; 55(1-2):50-74. PubMed ID: 36573379
[TBL] [Abstract][Full Text] [Related]
37. CYP450-derived oxylipins mediate inflammatory resolution.
Gilroy DW; Edin ML; De Maeyer RP; Bystrom J; Newson J; Lih FB; Stables M; Zeldin DC; Bishop-Bailey D
Proc Natl Acad Sci U S A; 2016 Jun; 113(23):E3240-9. PubMed ID: 27226306
[TBL] [Abstract][Full Text] [Related]
38. Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart.
Anwar-Mohamed A; El-Sherbeni AA; Kim SH; Althurwi HN; Zordoky BN; El-Kadi AO
Xenobiotica; 2012 Dec; 42(12):1235-47. PubMed ID: 22680237
[TBL] [Abstract][Full Text] [Related]
39. Soluble epoxide hydrolase: a promising therapeutic target for cardiovascular diseases.
Ni GH; Chen JF; Chen XP; Yang TL
Pharmazie; 2011 Mar; 66(3):153-7. PubMed ID: 21553642
[TBL] [Abstract][Full Text] [Related]
40. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.
Spector AA; Fang X; Snyder GD; Weintraub NL
Prog Lipid Res; 2004 Jan; 43(1):55-90. PubMed ID: 14636671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]